Revvity AlphaLISA Human Insulin-like Growth Factor 1 Detection Kit, 500 Assay Points

Formats:

• Our 500 assay point kit allows you to run 500 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).
• Our 5,000 assay point kit allows you to run 5,000 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).

Features:

• No-wash steps, no separation steps
• ELISA alternative technology
• Sensitive detection
• Broad sample compatibility
• Small sample volume
• Results in less than 3 hours
• Half the time of an ELISA assay

Insulin-like Growth Factor 1 (IGF1 or Somatomedin C) is 70 amino acids in length after being fully processed. IGF1 is produced primarily by the liver as an endocrine hormone as well as in target tissues in a paracrine/autocrine fashion. IGF1, via binding to the IGF receptor, acts as natural activators of the AKT signaling pathway, a stimulator of cell growth and multiplication as well as a potent inhibitor of programmed cell death. IGF1 mediates many of the growth-promoting effects of growth hormone by promoting the incorporation of sulfate into cartilage in many normal tissues. The insulin-like growth factor pathway plays a major role in cancer cell proliferation, survival and resistance to anti-cancer therapies underlying the importance of IGF1 as a serum biomarker in various diseases such as diabetes and cancer.

AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.